Monitoring Biomarkers After Pediatric Heart Surgery: A New Paradigm on the Horizon

Mehmet Aĝirbaşli, Akif Undar

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Until recently, risk scoring systems for adult patients consisted of only clinical criteria. Currently, we are experiencing an abundant surge of literature integrating a wide range of biomarker arrays to clinical criteria in assessing the risk in an adult. In fact, novel risk scoring systems such as Reynolds criteria have emerged by combining the validated biomarkers to the traditional risk factors. Novel biomarkers potentially improve clinical management of cardiovascular disease, but there are gaps in understanding their role during childhood. The reason might be related to relatively lower prevalence of cardiovascular disease in children compared to the adult population. One exceptional group is the children with congenital heart disease. Recent studies indicate that novel biomarkers can alert the clinician in a timely manner about neurological and myocardial injury and their inflammatory consequences. Current technologies enable us to measure several biomarkers using only a few microliters of plasma. The preliminary studies show that novel biomarkers in addition to the traditionally studied biomarkers can help the clinician to identify children at high risk following pediatric heart surgery. Future studies are needed to confirm the role of biomarkers in monitoring children after cardiopulmonary bypass.

Original languageEnglish (US)
Pages (from-to)10-15
Number of pages6
JournalArtificial organs
Volume37
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Pediatrics
Biomarkers
Surgery
Thoracic Surgery
Monitoring
Cardiovascular Diseases
Cardiopulmonary Bypass
Heart Diseases
Technology
Plasmas
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering

Cite this

@article{bc57f73380be45dc993a9fd22bf3db93,
title = "Monitoring Biomarkers After Pediatric Heart Surgery: A New Paradigm on the Horizon",
abstract = "Until recently, risk scoring systems for adult patients consisted of only clinical criteria. Currently, we are experiencing an abundant surge of literature integrating a wide range of biomarker arrays to clinical criteria in assessing the risk in an adult. In fact, novel risk scoring systems such as Reynolds criteria have emerged by combining the validated biomarkers to the traditional risk factors. Novel biomarkers potentially improve clinical management of cardiovascular disease, but there are gaps in understanding their role during childhood. The reason might be related to relatively lower prevalence of cardiovascular disease in children compared to the adult population. One exceptional group is the children with congenital heart disease. Recent studies indicate that novel biomarkers can alert the clinician in a timely manner about neurological and myocardial injury and their inflammatory consequences. Current technologies enable us to measure several biomarkers using only a few microliters of plasma. The preliminary studies show that novel biomarkers in addition to the traditionally studied biomarkers can help the clinician to identify children at high risk following pediatric heart surgery. Future studies are needed to confirm the role of biomarkers in monitoring children after cardiopulmonary bypass.",
author = "Mehmet Aĝirbaşli and Akif Undar",
year = "2013",
month = "1",
day = "1",
doi = "10.1111/j.1525-1594.2012.01573.x",
language = "English (US)",
volume = "37",
pages = "10--15",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "1",

}

Monitoring Biomarkers After Pediatric Heart Surgery : A New Paradigm on the Horizon. / Aĝirbaşli, Mehmet; Undar, Akif.

In: Artificial organs, Vol. 37, No. 1, 01.01.2013, p. 10-15.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Monitoring Biomarkers After Pediatric Heart Surgery

T2 - A New Paradigm on the Horizon

AU - Aĝirbaşli, Mehmet

AU - Undar, Akif

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Until recently, risk scoring systems for adult patients consisted of only clinical criteria. Currently, we are experiencing an abundant surge of literature integrating a wide range of biomarker arrays to clinical criteria in assessing the risk in an adult. In fact, novel risk scoring systems such as Reynolds criteria have emerged by combining the validated biomarkers to the traditional risk factors. Novel biomarkers potentially improve clinical management of cardiovascular disease, but there are gaps in understanding their role during childhood. The reason might be related to relatively lower prevalence of cardiovascular disease in children compared to the adult population. One exceptional group is the children with congenital heart disease. Recent studies indicate that novel biomarkers can alert the clinician in a timely manner about neurological and myocardial injury and their inflammatory consequences. Current technologies enable us to measure several biomarkers using only a few microliters of plasma. The preliminary studies show that novel biomarkers in addition to the traditionally studied biomarkers can help the clinician to identify children at high risk following pediatric heart surgery. Future studies are needed to confirm the role of biomarkers in monitoring children after cardiopulmonary bypass.

AB - Until recently, risk scoring systems for adult patients consisted of only clinical criteria. Currently, we are experiencing an abundant surge of literature integrating a wide range of biomarker arrays to clinical criteria in assessing the risk in an adult. In fact, novel risk scoring systems such as Reynolds criteria have emerged by combining the validated biomarkers to the traditional risk factors. Novel biomarkers potentially improve clinical management of cardiovascular disease, but there are gaps in understanding their role during childhood. The reason might be related to relatively lower prevalence of cardiovascular disease in children compared to the adult population. One exceptional group is the children with congenital heart disease. Recent studies indicate that novel biomarkers can alert the clinician in a timely manner about neurological and myocardial injury and their inflammatory consequences. Current technologies enable us to measure several biomarkers using only a few microliters of plasma. The preliminary studies show that novel biomarkers in addition to the traditionally studied biomarkers can help the clinician to identify children at high risk following pediatric heart surgery. Future studies are needed to confirm the role of biomarkers in monitoring children after cardiopulmonary bypass.

UR - http://www.scopus.com/inward/record.url?scp=84872369866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872369866&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1594.2012.01573.x

DO - 10.1111/j.1525-1594.2012.01573.x

M3 - Review article

C2 - 23305569

AN - SCOPUS:84872369866

VL - 37

SP - 10

EP - 15

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 1

ER -